Clinical Trial Update: Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor [Phase 1]

View source ↗

Summary

A Phase 1 neoadjuvant trial evaluating imatinib plus fampridine in KIT-mutant Gastrointestinal Stromal Tumor is currently recruiting at the University of Califo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Fampridine (4-aminopyridine)
• Imatinib (imatinib)

Snippet

Sponsor: University of California, San Diego | Conditions: Gastrointestinal Stromal Tumors | Phase 1 | Status: RECRUITING